Loan value:  $1.75-million (U.S.) in five tranches from a non-arm's-length party

Bonus securities:  295,422 shares and 2,564,081 warrants

Tranche 1:  1,086,956 warrants

Tranche 2:  113,635 shares and 568,181 warrants

Tranche 3:  68,181 shares and 340,909 warrants

Tranche 4:  52,631 shares and 263,157 warrants

Tranche 5:  60,975 shares and 304,878 warrants

Commission terms:  Each non-transferable warrant is exercisable as follows.

Tranche 1:  46 U.S. cents for a two-year period, subject to an acceleration right

Tranche 2:  44 U.S. cents for a two-year period, subject to an acceleration right

Tranche 3:  44 U.S. cents for a two-year period, subject to an acceleration right

Tranche 4:  38 U.S. cents for a two-year period, subject to an acceleration right

Tranche 5:  41 U.S. cents for a two-year period, subject to an acceleration right

Disclosure:  Refer to the company's news releases dated May 14, 2025, May 15, 2025, May 28, 2025, June 9, 2025, June 28, 2025, and July 8, 2025.